Lonza Group AG Stock Swiss Exchange
Equities
CH0013841017
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CHF | - |
May. 14 | Swiss Market Index Edges Up Ahead of Inflation Report | MT |
May. 14 | Global markets live: Apple, Sony, Vodafone, Booking, Walmart... |
Sales 2024 * | 6.66B 7.32B | Sales 2025 * | 7.62B 8.38B | Capitalization | 38.16B 41.97B |
---|---|---|---|---|---|
Net income 2024 * | 886M 974M | Net income 2025 * | 1.1B 1.21B | EV / Sales 2024 * | 6.15 x |
Net Debt 2024 * | 2.79B 3.07B | Net Debt 2025 * | 3.4B 3.74B | EV / Sales 2025 * | 5.45 x |
P/E ratio 2024 * |
43.2
x | P/E ratio 2025 * |
34.4
x | Employees | - |
Yield 2024 * |
0.85% | Yield 2025 * |
0.99% | Free-Float | 95.87% |
Latest transcript on Lonza Group AG
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 17-04-24 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 21-11-30 |
Maria Nunez
COO | Chief Operating Officer | 55 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 14-04-15 |
Director/Board Member | 66 | 14-04-15 | |
Marion Helmes
BRD | Director/Board Member | 58 | 22-05-04 |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.85B | |
-0.09% | 42.82B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B | |
-6.26% | 11.58B |